糖尿病監測設備市場（按產品類型、適應症、最終用戶和地區分類）

Diabetes Monitoring Devices Market, By Product Type, By Indication, By End User, By Geography

出版日期: 2025年03月03日 | 出版商:

Coherent Market Insights | 英文 170 Pages | 商品交期: 2-3個工作天內

價格

簡介目錄

預計 2025 年全球糖尿病監測設備市場規模為 135 億美元，到 2032 年將達到 237.4 億美元，2025 年至 2032 年的年複合成長率（CAGR）為 8.4%。

報告範圍		報告詳細資訊
基準年	2024	2025年的市場規模	135億美元
效能數據	從2020年到2024年	預測期	2025年至2032年
預測期：2025-2032年複合年成長率：	8.40%	2032年價值預測	237.4億美元

數字。 2025年糖尿病監測設備市場佔有率（按地區）

糖尿病患者和臨床醫生使用血糖值監測儀來監測和控制患者的血糖值。這些設備大部分都是由醫院外的患者使用的。這些患者中有許多都是老年人，行動不便，視力不佳。血糖值儀有一個測量端口，患者可以將一張經過校準的小試紙放在該端口上，並將血液塗抹在該試紙上進行分析。為了適應靈活性有限的用戶，測試條不能太小而難以用戶操作。

市場動態：

全球糖尿病盛行率的上升是推動糖尿病監測設備市場成長的主要因素。根據國際糖尿病聯盟的最新數據，2021年全球約有5.37億成年人患有糖尿病，預計2045年將上升到7.83億。糖尿病對中低收入國家的影響尤其嚴重，每年導致超過120萬人死亡。全球糖尿病患者的不斷成長和健康意識的增強使得有效的血糖監測和疾病管理更加受到重視。

不過，這個市場也面臨一定的挑戰。對醫務人員進行操作先進設備並將其納入治療計劃的持續培訓成本也導致了價格上漲。政府透過報銷計畫進行的干涉有限，進一步抑制了糖尿病患者的負擔能力。科技有望徹底改變糖尿病管理，但只有解決了定價障礙，其好處才會惠及大眾。除非開發出替代方案，使技術創新更加經濟實惠，否則高價格可能會繼續限制市場擴張，特別是在最開發中地區。

儘管存在這些挑戰，但市場仍有一些成長機會。新型穿戴式微創技術的開發可望徹底改變糖尿病監測。早期的例子包括連續血糖監測系統，該系統無需刺穿手指，並且可以佩戴長達 14 天。此外，以最小的痛苦和努力提取間質液的貼片式感測器也正在實驗開發中。如果此類解決方案價格實惠且廣泛可用，它們將有助於將管理從不一致的自我記錄轉變為近乎持續的自動監控。這可以使糖尿病患者透過及時和明智的干涉來更好地控制病情。

本研究的主要特點

本報告對全球糖尿病監測設備市場進行了詳細分析，並提供了預測期（2025-2032）的市場規模和年複合成長率(CAGR)，假設 2024 年為基準年。
它還強調了各個領域的潛在商機，並說明了該市場的引人注目的投資提案矩陣。
它還提供了有關市場促進因素、限制因素、機會、新產品發布和核准、市場趨勢、區域前景和主要企業採用的競爭策略的重要見解。
它根據公司亮點、產品系列、關鍵亮點、財務表現和策略等參數，介紹了全球糖尿病監測設備市場的主要企業概況。
本報告的見解將使負責人和企業經營團隊能夠就未來的產品發布、新興趨勢、市場擴張和行銷策略做出明智的決策。
全球糖尿病監測設備市場報告迎合了該行業的各個相關人員，例如投資者、供應商、產品製造商、經銷商、新進入者和金融分析師。
相關人員可以透過用於分析全球糖尿病監測設備市場的各種策略矩陣來更輕鬆地做出決策。

Report Coverage	Report Details
Base Year:	2024	Market Size in 2025:	USD 13.5 Bn
Historical Data for:	2020 To 2024	Forecast Period:	2025 To 2032
Forecast Period 2025 to 2032 CAGR:	8.40%	2032 Value Projection:	USD 23.74 Bn

Blood glucose monitors are used by diabetic patients and clinicians to monitor and to help control a patient's blood glucose level. Most of these devices are used by patients outside the hospital setting. Many of these patients are elderly, with limited manual dexterity and impaired vision. Blood glucose monitors have a reading port into which patients place a small calibrated test strip, onto which they have applied blood, for analysis. In order to accommodate users with limited manual dexterity, the test strips cannot be too small by making the strip difficult for the user to handle.

Market Dynamics:

Growing prevalence of diabetes across the globe is a major factor driving the growth of diabetes monitoring devices market. According to the latest data by the International Diabetes Federation, approximately 537 million adults were living with diabetes in 2021 which is projected to rise to 783 million by 2045. Diabetes disproportionately affects lower and middle-income countries and accounts for over 1.2 million deaths each year. With the rising diabetic population worldwide and increasing health awareness, there is greater emphasis on efficient glucose monitoring and management of the disease.

However, the market also faces certain challenges. The costs involved in continuous training of healthcare providers to operate and integrate advanced devices into treatment plans also contribute to higher prices. Limited government intervention through reimbursement schemes further restrains affordability of diabetic patients. While technology holds promise to revolutionize diabetes management, its benefits can only percolate to masses if pricing obstacles are addressed. Unless alternatives are developed to make innovation more affordable and accessible, high prices will continue limiting market expansion especially in less developed regions.

Despite these challenges, the market presents several opportunities for growth. The development of novel wearable and minimally-invasive technologies is expected to transform diabetes monitoring. A few early examples include continuous glucose monitoring systems that do not require finger pricks and can be worn for up to 14 days. Patch-like sensors have also been trialed that extract interstitial fluid with little pain or hassle. If such solutions become widely accessible in an affordable way, they may help shift management from inconsistent self-tracking to near-constant automated oversight. This could help diabetics better control their condition through informed timely interventions.

Key features of the study:

This report provides in-depth analysis of the global diabetes monitoring devices market, and provides market size (US$ Bn) and compound annual growth rate (CAGR %) for the forecast period (2025-2032), considering 2024 as the base year
It elucidates potential revenue opportunities across different segments and explains attractive investment proposition matrices for this market
This study also provides key insights about market drivers, restraints, opportunities, new product launches or approval, market trends, regional outlook, and competitive strategies adopted by key players
It profiles key players in the global diabetes monitoring devices market based on the following parameters - company highlights, products portfolio, key highlights, financial performance, and strategies
Key companies covered as a part of this study include i-SENS, Inc., Ascensia Diabetes Care Holdings AG., Bayer AG, F. Hoffmann-La Roche Ltd, Johnson & Johnson Services, Inc., Medtronic, Dexcom, Abbott, Labiotech UG, ARKRAY, Inc., Cnoga, Sanofi, and Lifescan
Insights from this report would allow marketers and the management authorities of the companies to make informed decisions regarding their future product launches, type up-gradation, market expansion, and marketing tactics
Global diabetes monitoring devices market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts
Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the global diabetes monitoring devices market

Global Diabetes Monitoring Devices Market Detailed Segmentation:

By Product Type:
- Self-Monitoring Blood Glucose Devices
- Continuous Glucose Monitoring Devices
By Indication:
- Type-I Diabetes
- Type-II Diabetes
- Gestational Diabetes
By End User:
- Hospitals
- Clinics
- Ambulatory Surgical Center
- Home Care Settings
- Others
By Region
- North America
- Europe
- Asia Pacific
- Latin America
- Middle East and Africa
Company Profiles
- i-SENS, Inc.
- Ascensia Diabetes Care Holdings AG.
- Bayer AG
- Hoffmann-La Roche Ltd
- Johnson & Johnson Services, Inc.
- Medtronic
- Dexcom
- Abbott
- Labiotech UG
- ARKRAY, Inc.
- Cnoga
- Sanofi
- Lifescan

1. Research Objectives and Assumptions

Research Objectives
Assumptions
Abbreviations

2. Market Purview

Report Description
- Market Definition and Scope
Executive Summary
- Market Snippet, By Product Type
- Market Snippet, By Indication
- Market Snippet, By End User
- Market Snippet, By Region
Coherent Opportunity Map (COM)

3. Market Dynamics, Regulations, and Trends Analysis

Market Dynamics
- Growing prevalence of diabetes
- Technological advancements in devices
Key Highlights
Regulatory Scenario
Recent Trends
Product Launches/Approvals
PEST Analysis
PORTER's Analysis
Mergers, Acquisitions and Collaborations

4. Global Diabetes Monitoring Devices Market- Impact of Coronavirus (COVID-19) Pandemic

COVID-19 Epidemiology
Supply Side and Demand Side Analysis
Economic Impact

5. Global Diabetes Monitoring Devices Market, By Product Type, 2020-2032, (US$ Bn)

Introduction
- Market Share Analysis, 2025 and 2032 (%)
- Y-o-Y Growth Analysis, 2021 - 2032
- Segment Trends
Self-Monitoring Blood Glucose Devices
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (US$ Bn)
Continuous Glucose Monitoring Devices
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (US$ Bn)

6. Global Diabetes Monitoring Devices Market, By Indication, 2020-2032, (US$ Bn)

Introduction
- Market Share Analysis, 2025 and 2032 (%)
- Y-o-Y Growth Analysis, 2021 - 2032
- Segment Trends
Type-I Diabetes
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (US$ Bn)
Type-II Diabetes
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (US$ Bn)
Gestational Diabetes
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (US$ Bn)

7. Global Diabetes Monitoring Devices Market, By End User, 2020-2032, (US$ Bn)

Introduction
- Market Share Analysis, 2025 and 2032 (%)
- Y-o-Y Growth Analysis, 2021 - 2032
- Segment Trends
Hospitals
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (US$ Bn )
Clinics
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (US$ Bn)
Ambulatory Surgical Center
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (US$ Bn)
Others
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (US$ Bn)

8. Global Diabetes Monitoring Devices Market, By Region, 2020-2032, (US$ Bn)

Introduction
- Market Share Analysis, By Region, 2025 and 2032 (%)
- Y-o-Y Growth Analysis, For Region, 2021 -2032
- Country Trends
North America
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Product Type, 2020-2032, (US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Indication, 2020-2032, (US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By End User, 2020-2032, (US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2020-2032, (US$ Bn)
  - U.S.
  - Canada
Europe
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Product Type, 2020-2032, (US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Indication, 2020-2032, (US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By End User, 2020-2032, (US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2020-2032, (US$ Bn)
  - Germany
  - U.K.
  - Spain
  - France
  - Italy
  - Russia
  - Rest of Europe
Asia Pacific
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Product Type, 2020-2032, (US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Indication, 2020-2032, (US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By End User, 2020-2032, (US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2020-2032, (US$ Bn)
  - China
  - India
  - Japan
  - Australia
  - South Korea
  - ASEAN
  - Rest of Asia Pacific
Latin America
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Product Type, 2020-2032, (US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Indication, 2020-2032, (US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By End User, 2020-2032, (US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2020-2032, (US$ Bn)
  - Brazil
  - Argentina
  - Mexico
  - Rest of Latin America
Middle East
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Product Type, 2020-2032, (US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Indication, 2020-2032, (US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By End User, 2020-2032, (US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2020-2032, (US$ Bn)
  - GCC Countries
  - Israel
  - Rest of Middle East
Africa
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Product Type, 2020-2032, (US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Indication, 2020-2032, (US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By End User, 2020-2032, (US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Country/Region, 2020-2032, (US$ Bn)
  - South Africa
  - North Africa
  - Central Africa

9. Competitive Landscape

Company Profiles
- i-SENS, Inc.
  - Company Highlights
  - Product Portfolio
  - Key Developments
  - Financial Performance
  - Strategies
- Ascensia Diabetes Care Holdings AG.
  - Company Highlights
  - Product Portfolio
  - Key Developments
  - Financial Performance
  - Strategies
- Bayer AG
  - Company Highlights
  - Product Portfolio
  - Key Developments
  - Financial Performance
  - Strategies
- Hoffmann-La Roche Ltd
  - Company Highlights
  - Product Portfolio
  - Key Developments
  - Financial Performance
  - Strategies
- Johnson & Johnson Services, Inc.
  - Company Highlights
  - Product Portfolio
  - Key Developments
  - Financial Performance
  - Strategies
- Medtronic
  - Company Highlights
  - Product Portfolio
  - Key Developments
  - Financial Performance
  - Strategies
- Dexcom
  - Company Highlights
  - Product Portfolio
  - Key Developments
  - Financial Performance
  - Strategies
- Abbott
  - Company Highlights
  - Product Portfolio
  - Key Developments
  - Financial Performance
  - Strategies
- Labiotech UG
  - Company Highlights
  - Product Portfolio
  - Key Developments
  - Financial Performance
  - Strategies
- ARKRAY, Inc.
  - Company Highlights
  - Product Portfolio
  - Key Developments
  - Financial Performance
  - Strategies
- Cnoga
  - Company Highlights
  - Product Portfolio
  - Key Developments
  - Financial Performance
  - Strategies
- Sanofi
  - Company Highlights
  - Product Portfolio
  - Key Developments
  - Financial Performance
  - Strategies
- Lifescan
  - Company Highlights
  - Product Portfolio
  - Key Developments
  - Financial Performance
  - Strategies
- Analysts' Views